Using an automated CE-SDS platform in efficient biosimilar comparability studies is a free-to-attend webinar which will be hosted by DDW and supported by Bio-Techne on 29 September at 4PM BST. Register here for this free, virtual event.
Join Dr Richard L Easton, Technical Director of Structural Analysis at BioPharmSpec as he discusses the use of the automated Maurice platform, from ProteinSimple, to provide capillary electrophoresis-sodium dodecyl sulphate (CE-SDS) data for biosimilar comparability studies. BioPharmaSpec is a US and UK-based CRO, specialising in the structural and physicochemical characterisation of biopharmaceuticals, with technical expertise in Antibody Drug Conjugates, biosimilars and many more.
During this webinar, Easton will present data from studies with monoclonal antibodies, heavily glycosylated species and PEGylated species showing how the Maurice platform can be used to provide reliable insights into the structure of different types of biopharmaceuticals, including assessments of size heterogeneity, presence of partial species in monoclonal antibody preparations, impurity analyses and batch to batch comparability.
This webinar will benefit anyone who is interested in understanding how to optimise their analytical methods to accelerate biosimilar development.
Register for free here.